Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today December 20
February 25, 2019 09:50
Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer
Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA
February 21, 2019 16:00
ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venue
February 21, 2019 13:35
KCI Launches ABTHERA™ Therapy in Japan
KCI, an Acelity Company, today announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan, expanding access to the Company’s surgical portfolio in the country. ABTHERA™ Therapy i
February 19, 2019 16:50
Boehringer Ingelheim and Lilly’s CAROLINA® cardiovascular outcome trial for Trajenta® meets primary endpoint of non-inferiority compared to glimepiride
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced CAROLINA® (CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with type 2 diabetes) met its primary endpoin
February 19, 2019 13:45
Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implementation of an automation solution designed to streamline the process of c
February 14, 2019 11:40
SpeeDx Develops Multiplex Test for Respiratory Viruses
SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the Australian 2019 flu seaso
February 13, 2019 09:50
Clean management of Laser Gum Bleaching with Dr. Yumi Jung of MAGIC KISS Dental Clinic in Korea
When someone mentions whitening (Bleaching), you will usually think of whitening of the teeth or face. But some people are worried about their black or dark gums. So, Dr. Yumi Jung, the chief denti
February 12, 2019 16:50
European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ADCETRIS (brentuximab vedotin) to include tr
February 08, 2019 11:20
Takeda Announces Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL - a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia A- at EAHAD 2019
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, has today announced results from its phase IIIb/IV clinical trial for ADYNOVATE
February 04, 2019 13:50
Takeda Reports Third Quarter FY2018 Results
Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): Underlying Revenue +4.8% year-to-date with growth of prescription drug portfolio in all regions · Solid Underlying Revenue growth of
February 01, 2019 13:28
G+FLAS Life Sciences, a Korean CRISPR/Cas Genome Editing Company, Licenses DNA-Free Genome Editing Technologies
G+FLAS Life Sciences, Inc. (G+FLAS), a CRISPR/Cas genome editing company in South Korea, announced that they licensed two patents regarding Non-GMO ways of plant genome engineering. The licensed DNA-f
February 01, 2019 11:45
Takeda Scoops Prestigious Global Top Employers® Award for Second Year Running
Takeda Pharmaceutical Company Limited [TOKYO: 4502 / NYSE: TAK], (“Takeda”) today announced it has become part of a select group of only 12 to receive global Top Employer® status for 2019. Established
January 31, 2019 18:25
Morinaga Milk's Probiotic Bifidobacterium infantis M-63 Alleviates Mental Stress of Flood Victims
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced new research showing that consumption of its proprietary probiotic Morinaga Bifidobacterium inf
January 31, 2019 18:10
Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner
Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its exclusive di
January 30, 2019 13:45
Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
Takeda Pharmaceutical Company Limited [TSE:4502 / NYSE:TAK] (“Takeda”) today announced that the pivotal Phase 3 trial of its dengue vaccine candidate met the primary efficacy endpoint. This first anal
January 30, 2019 11:55
Ensuring the Health and Safety of Global Aquaculture: House Wellness Foods’ Feed LP20® Boosts Commercial Nile Tilapia Production, Reduces Antibiotic Use
In the ongoing effort to battle world hunger and expand the production of healthy livestock, House Wellness Foods’ groundbreaking, immunobiotic-based Feed LP20® has once again produced conclusive rese
January 24, 2019 14:59
ACCUNIQ to Supply Body Composition Analyzer to World Gym
SELVAS Healthcare Inc. has signed a contract with World Gym International, LLC. to supply its body composition analyzer ACCUNIQ to the World Gym Franchisees. Under the contract, SELVAS Healthcare w
January 22, 2019 16:15
Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments
Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s hea
January 22, 2019 13:50
ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.
ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under t
January 22, 2019 11:55
Metabolon Appoints Michael Rasche as President of International Business
Metabolon, the world leader in metabolomics, today announced that Michael Rasche joined the company as President of International Business. Michael will report to Rohan Hastie, Metabolon’s President a
January 18, 2019 11:05
Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer
Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly targeted, oral, small-molecule drugs to treat NASH and cancer, announced today the appo
January 11, 2019 09:00
Korean Health Food Distribution Brand Nature Food Distributes ‘Chong Kun Dang 6-year-old Red Ginseng Gold’ Abroad
Ewha Company said its food brand, Nature Food, will begin an international distribution of health food product, ‘Chong Kun Dang 6-year-old Red Ginseng Gold.’ Red ginseng has many medicinal effects
January 11, 2019 08:55
R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide
The new Code of Practice of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) came into effect on 1 January 2019. The 2019 Code is marked by two important changes.
January 10, 2019 09:40
FotoFinder Systems: Artificial Intelligence Revolutionizes Skin Cancer Detection
“Artificial Intelligence” (AI) is currently on everyone's lips. Experts say companies need to focus on three aspects of AI to play a leading role in the topic: latest programming insights, importance
January 10, 2019 09:10
Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.
ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely availab
«
102
103
104
105
106
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
43,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice